Aptose Biosciences (FRA:LTI) Days Payable : 0.00 (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Aptose Biosciences Days Payable?

Aptose Biosciences's average Accounts Payable for the three months ended in Sep. 2024 was €4.13 Mil. Aptose Biosciences's Cost of Goods Sold for the three months ended in Sep. 2024 was €0.00 Mil.

The historical rank and industry rank for Aptose Biosciences's Days Payable or its related term are showing as below:

FRA:LTI's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 127.37
* Ranked among companies with meaningful Days Payable only.

Aptose Biosciences's Days Payable stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00). stayed the same

Aptose Biosciences Days Payable Historical Data

The historical data trend for Aptose Biosciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Days Payable Chart

Aptose Biosciences Annual Data

Trend

May14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Aptose Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Aptose Biosciences's Days Payable

For the Biotechnology subindustry, Aptose Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptose Biosciences's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptose Biosciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Aptose Biosciences's Days Payable falls into.

Aptose Biosciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Aptose Biosciences's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (5.972	+	5.544)	/	2 )	/	0	*	365
=	5.758					/	0	*	365
=	N/A

Aptose Biosciences's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (6.606	+	1.649)	/	2 )	/	0	*	365 / 4
=	4.1275					/	0	*	365 / 4
=	N/A

Aptose Biosciences Days Payable Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptose Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (FRA:LTI) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

APTO:USA 0UI8:UK LTI:Germany APS:Canada

Address

251 Consumers Road, Suite 1105, Toronto, ON, CAN, M2J 4R3

Website

https://www.aptose.com

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Aptose Biosciences Headlines

No Headlines